课题基金 / 基金详情

NSABP CO-7

NSABP CO-7
NSABP CO-7
批准号：
7607580
负责人：
Scott Henry Kurtzman
金额：
$0.03万
依托单位：
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-04-01 至 2008-03-31
来源：
https://reporter.nih.gov/project-details/7607580
关键词：
Colon CarcinomaComputer Retrieval of Information on Scientific Projects DatabaseDisease-Free SurvivalExcisionFluorouracilFundingGrantInstitutionLeucovorinNational Surgical Adjuvant Breast and Bowel ProjectPatientsRelative (related person)ResearchResearch PersonnelResourcesSourceStagingUnited States National Institutes of Healthoxaliplatin

项目摘要

项目成果

Scott Henry Kurtzman的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary aim of this study is to compare the relative efficacy of Fluorouracil (5-FU) + Leucovorin (LV) + Oxaliplatin (FLOX) with that of 5-FU + LV in prolonging disease-free survival among patients who have undergone a potentially curative resection of a stage II or III carcinoma of the colon. The secondary aim of the study is to compare the relative efficacy of FLOX with that of FL in prolonging Survival (S).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: NSABP P-2: STAR
NSABP B-28
NSABP B-31
NSABP B-35